Mark Bodman‐Smith

2.2k citations

49 papers · 1.7k indexed · h-index 19

Impact in

Immunology top 5%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
Rheumatology top 5%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies

Papers in

Immunology 30
- Immunotherapy and Immune Responses 15
- Immune Cell Function and Interaction 15
- T-cell and B-cell Immunology 14
- Toxin Mechanisms and Immunotoxins 5
- Immune responses and vaccinations 3
Virology 2

Co-authors: Angus Dalgleish Martin Salden Michael R. Ehrenstein Geraldine Cambridge Jonathan Edwards A D Webster Maria Leandro Barbara E. Kream
Journals: Immunology (3 papers)Frontiers in Immunology (3 papers)Clinical & Experimental Immunology (3 papers)Cancer Immunology Immunotherapy (3 papers)Human Gene Therapy (2 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Mark Bodman‐Smith

49 papers receiving 1.6k citations

Peers

Countries citing papers authored by Mark Bodman‐Smith

Since Specialization

Citations

This map shows the geographic impact of Mark Bodman‐Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bodman‐Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bodman‐Smith more than expected).

Fields of papers citing papers by Mark Bodman‐Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bodman‐Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bodman‐Smith. The network helps show where Mark Bodman‐Smith may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Bodman‐Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Bodman‐Smith Line = papers co-authored together Mark Bodman‐Smith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Inhalation of SP-101 Followed by Inhaled Doxorubicin Results in Robust and Durable hCFTRΔR Transgene Expression in the Airways of Wild-Type and Cystic Fibrosis Ferrets Human Gene Therapy ·Katherine J. D. A. Excoffon, Mark Bodman‐Smith, PJDO Lima, Robert Schulingkamp, Tamotsu Takada, Antonio Viruez-Soto, Matin Mir Abdul, Ruselle Meade, Maria P. Limberis, Eric Yuen, Roland Kolbeck	2024	5
2	SP-101, A Novel Adeno-Associated Virus Gene Therapy for the Treatment of Cystic Fibrosis, Mediates Functional Correction of Primary Human Airway Epithelia From Donors with Cystic Fibrosis Human Gene Therapy ·Katherine J. D. A. Excoffon, Tamotsu Takada, 加奈子井上, Ronald Anglade, Raúl Manuel-Posada, H. Kaneoka, 圭子鈴木, Ruselle Meade, Maria P. Limberis, Mark Bodman‐Smith, Guia Guffanti, Roland Kolbeck	2024	8
3	Durable transgene expression and efficient re-administration after rAAV2.5T-mediated fCFTRΔR gene delivery to adult ferret lungs Molecular Therapy — Methods & Clinical Development ·Yinghua Tang, A Roiati, Jaime Carlos Menjivar, Zehua Feng, Oishi Mitra, Peipei Wu, Mark Bodman‐Smith, Maria P. Limberis, Roland Kolbeck, Katherine J. D. A. Excoffon, Ziying Yan, John F. Engelhardt	2024	2
4	Killer to cure: Expression and production costs calculation of tobacco plant‐made cancer‐immune checkpoint inhibitors Plant Biotechnology Journal ·Lin W. Leung, Francisco José Roig Vázquez, Ryan Mackey Pagano, Patrick Opdensteinen, U. Balarabe, Julian K‐C., Mark Bodman‐Smith, Johannes F. Buyel, Audrey Y‐H. Teh	2023	16
5	IV BCG Vaccination and Aerosol BCG Revaccination Induce Mycobacteria-Responsive γδ T Cells Associated with Protective Efficacy against M. tb Challenge Vaccines ·Kyeonah Yu, Charlotte Sarfas, Laura Sibley, PATRICIA CAMERA, Lone Seeberg, Mike Dennis, Jesús Jiménez Valdés, Andrew White, Mark Bodman‐Smith, Sally Sharpe	2023	5
6	Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy Frontiers in Immunology ·Lin W. Leung, Jonathan Caron, Angus Dalgleish, Mark Bodman‐Smith	2023	5
7	Cheap and Commonplace: Making the Case for BCG and γδ T Cells in COVID-19 Frontiers in Immunology ·Kyeonah Yu, Sally Sharpe, Andrew White, Mark Bodman‐Smith	2021	3
8	Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine Translational Oncology ·Putu Wida Gunawan, Cici Kurniati, Deborah M. Green, Mark Bodman‐Smith, 重規宇野, Katherine Bodman-Smith, John Copier, Gary R. Coulton, Alberto Fusi, Angus Dalgleish	2018	3
9	Effect of the Modification of p24 Peptide Antigen on Dendritic Cell Uptake and T Cell Activation Current HIV Research ·Peter L. Smith, W.E. Kummer, Yan Mao, Kemal EROL, 廖漢敦, Maja A. Sommerfelt, P. V. Prasanna Kumari, Arnt‐Ove Hovden, J Cornet, Angus Dalgleish, Mark Bodman‐Smith	2016	2
10	Acetate supplementation modulates brain adenosine metabolizing enzymes and adenosine A2Areceptor levels in rats subjected to neuroinflammation Journal of Neuroinflammation ·Mark Bodman‐Smith, Dhaval P. Bhatt, Jonathan D. Geiger, Thad A. Rosenberger	2014	19
11	Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy Cancer Immunology Immunotherapy ·Daniel Fowler, John Copier, Natalie Wilson, Angus Dalgleish, Mark Bodman‐Smith	2011	44
12	The effect of colorectal cancer upon host peripheral immune cell function Colorectal Disease ·Claire F. Evans, В.А. Марченко, Mark Bodman‐Smith, Angus Dalgleish, Yan Li	2009	25
13	Impact of surgery on immunologic function: comparison between minimally invasive techniques and conventional laparotomy for surgical resection of colorectal tumors The American Journal of Surgery ·Charles Evans, Christine Galustian, M. Gur-Aryeh, R Hagger, David M. Melville, Mark Bodman‐Smith, Akmal Buronov, A. M. Gudgeon, Angus Dalgleish	2008	60
14	Treatment of murine collagen‐induced arthritis by the stress protein BiP via interleukin‐4–producing regulatory T cells: A novel function for an ancient protein Arthritis & Rheumatism ·Rebecca J. Brownlie, Linda K. Myers, Paul H. Wooley, Valerie Corrigall, Mark Bodman‐Smith, G S Panayi, Stephen J. Thompson	2006	71
15	Antibody response to the human stress protein BiP in rheumatoid arthritis British journal of rheumatology ·Mark Bodman‐Smith	2004	45
16	Inhibition of antigen‐presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: Relevance to the treatment of inflammatory arthritis Arthritis & Rheumatism ·Valerie Corrigall, Mark Bodman‐Smith, ΜΙΛΤΙΑΔΗΣ ΓΚΟΛΕΜΗΣ, Г.Б. Сочилин, G S Panayi	2004	83
17	BiP, a putative autoantigen in rheumatoid arthritis, stimulates IL-10-producing CD8-positive T cells from normal individuals British journal of rheumatology ·Mark Bodman‐Smith	2003	42
18	The Human Endoplasmic Reticulum Molecular Chaperone BiP Is an Autoantigen for Rheumatoid Arthritis and Prevents the Induction of Experimental Arthritis The Journal of Immunology ·Valerie Corrigall, Mark Bodman‐Smith, M Fife, Benito Cañas, Linda K. Myers, Paul H. Wooley, Cecilia Soh, Norman A. Staines, Darryl Pappin, Suzanne E. Berlo, Willem van Eden, Ruurd van der Zee, Jerry S. Lanchbury, G S Panayi	2001	151
19	Decreased expression of FcγRIII (CD16) by γδ T cells in patients withrheumatoid arthritis Immunology ·Mark Bodman‐Smith, Arthi Anand, Véronique Durand, Pierre Youinou, Peter M. Lydyard	2000	11
20	Polymorphism and expression of the galactosyltransferase‐associated protein kinase gene in normal individuals and galactosylation‐defective rheumatoid arthritis patients Arthritis & Rheumatism ·Peter J. Delves, Torben Lund, John S. Axford, P. Rubatta, Peter M. Lydyard, Lorna Mackenzie, Mark Bodman‐Smith, Vincent J. Kidd	1990	17

About Mark Bodman‐Smith

Mark Bodman‐Smith is a scholar working on Immunology, Virology, Biological Psychiatry, Oncology and Microbiology, having authored 49 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (15 papers), Immune Cell Function and Interaction (15 papers), T-cell and B-cell Immunology (14 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Toxin Mechanisms and Immunotoxins (5 papers), CAR-T cell therapy research (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Immune responses and vaccinations (3 papers). The work is most often cited by research in Immunology (755 citations), Rheumatology (318 citations), Oncology (356 citations), Radiology, Nuclear Medicine and Imaging (290 citations) and Cell Biology (152 citations). Mark Bodman‐Smith has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Angus Dalgleish, Martin Salden, Michael R. Ehrenstein, Geraldine Cambridge, Jonathan Edwards, A D Webster, Maria Leandro, Barbara E. Kream, Lawrence G. Raisz and Ernesto Canalis. Their work appears in journals such as Immunology, Frontiers in Immunology, Clinical & Experimental Immunology, Cancer Immunology Immunotherapy and Human Gene Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact